Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cyclase

It now appears that many hormones (e.g. glucagon and adrenaline) in both animals and plants exert their effects by, as a first step, decreasing or increasing cyclic AMP within the cell. This may possibly occur by modification of the activity of the enzyme AMP cyclase which generates cyclic AMP from ATP. [Pg.121]

Adenoviridae Adenovirus, type 2 Adenylate cyclase Adenyl cyclase O-Adenylylation Adenylyl cyclase... [Pg.16]

Brain adenylate cyclase Brain imaging Brains Brake bands Brake blocks Brake facings Brake fluids... [Pg.126]

Vanadium. Vanadium is essential in rats and chicks (85,156). Estimated human intake is less than 4 mg/d. In animals, deficiency results in impaired growth, reproduction, and Hpid metaboHsm (157), and altered thyroid peroxidase activities (112). The levels of coen2yme A and coen2yme Q q in rats are reduced and monoamine oxidase activity is increased when rats are given excess vanadium (157). Vanadium may play a role in the regulation of (NaK)—ATPase, phosphoryl transferases, adenylate cyclase, and protein kinases (112). [Pg.388]

Two AT-II receptors, AT and AT2 are known and show wide distribution (27). The AT receptor has been cloned and predominates ia regions iavolved ia the regulation of blood pressure and water and sodium retention, eg, the aorta, Hver, adrenal cortex, and ia the CNS ia the paraventricular nucleus, area postrema, and nucleus of the soHtary tract. AT2 receptors are found primarily ia the adrenal medulla, utems, and ia the brain ia the locus coeruleus and the medial geniculate nucleus. AT receptors are GCPRs inhibiting adenylate cyclase activity and stimulating phosphoHpases C, A2, and D. AT2 receptors use phosphotyrosiae phosphatase as a transduction system. [Pg.527]

The ANP leceptoi exists in two forms, ANP and ANPg, both of which have been cloned. These membrane-bound guanylate cyclases have a single transmembrane domain, an intracellular protein kinase-like domain, and a catalytic cyclase domain, activation of which results in the accumulation of cychc guanosine monophosphate (cGMP). A third receptor subtype (ANP ) has been identified that does not have intrinsic guanylate cyclase activity and may play a role in the clearance of ANP. [Pg.528]

Opiates iateract with three principal classes of opioid GPCRs )J.-selective for the endorphiQS,5-selective for enkephalins, and K-selective for dynorphias (51). AU. three receptors have been cloned. Each inhibits adenylate cyclase, can activate potassium channels, and inhibit A/-type calcium channels. The classical opiates, morphine and its antagonists naloxone (144) and naltrexone (145), have moderate selectivity for the. -receptor. Pharmacological evidence suggests that there are two subtypes of the. -receptor and three subtypes each of the 5- and K-receptor. An s-opiate receptor may also exist. [Pg.545]

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Peptide. Vasoactive intestinal peptide (VIP)... [Pg.578]

J (339), a 28-amino acid peptide, is a member of a family of stmctuially related peptides that includes secretin [1393-25-5] (340), growth hormone releasing factor (GRF), and pituitary adenylate cyclase-activating peptide (PACAP) [137061(341) (83). [Pg.578]

The effects of VIP and PACAP are mediated by three GPCR subtypes, VIP, VIP2, and PACAP receptor, coupled to the activation of adenjiate cyclase (54). The VIP subtype is localized ia the lung, Hver, and iatestiae, and the cortex, hippocampus, and olfactory bulb ia the CNS. The VIP2 receptor is most abundant ia the CNS, ia particular ia the thalamus, hippocampus, hypothalamus, and suprachiasmatic nucleus. PACAP receptors have a wide distribution ia the CNS with highest levels ia the olfactory bulb, the dentate gyms, and the cerebellum (84). The receptor is also present ia the pituitary. The VIP and PACAP receptors have been cloned. [Pg.578]

Receptors linked to guanylyl cyclase and which catalyze the formation of guanosine triphosphate (GMP) to guanosine-3A -cychc monophosphate (cychc GMP) include those for atrial natriuretic factor (ANF) and endothehal-derived relaxing factor (EDRF), mediating vasodilatation, and nitric oxide [10102 3-9], NO, or a clearly related derivative. [Pg.272]

The ability of receptors to couple to G-proteins and initiate GTPase activity may also be independent of ligand. Thus, specific mutations in a- and P-adrenergic receptors have led to receptors that mediate agonist-independent activation of adenylyl cyclase (69,70). These mutations presumably mimic the conformational state of the ligand-activated receptor when they are activated conventionally by ligands. [Pg.279]

Lithium. In the lithium carbonate treatment of certain psychotic states, a low incidence (3.6%) of hypothyroidism and goiter production have been observed as side effects (6,36) (see Psychopharmacologicalagents). It has been proposed that the mechanism of this action is the inhibition of adenyl cyclase. Lithium salts have not found general acceptance in the treatment of hyperthyroidism (see Lithiumand lithium compounds). [Pg.53]


See other pages where Cyclase is mentioned: [Pg.1162]    [Pg.457]    [Pg.457]    [Pg.191]    [Pg.95]    [Pg.381]    [Pg.516]    [Pg.518]    [Pg.518]    [Pg.532]    [Pg.547]    [Pg.553]    [Pg.564]    [Pg.566]    [Pg.575]    [Pg.449]    [Pg.449]    [Pg.271]    [Pg.278]    [Pg.278]    [Pg.279]    [Pg.279]    [Pg.280]    [Pg.281]    [Pg.281]    [Pg.438]    [Pg.438]    [Pg.443]    [Pg.156]    [Pg.205]    [Pg.206]    [Pg.492]    [Pg.284]    [Pg.123]    [Pg.129]    [Pg.359]    [Pg.359]    [Pg.359]   
See also in sourсe #XX -- [ Pg.134 ]

See also in sourсe #XX -- [ Pg.134 ]

See also in sourсe #XX -- [ Pg.75 ]

See also in sourсe #XX -- [ Pg.53 ]

See also in sourсe #XX -- [ Pg.7 , Pg.109 , Pg.110 ]

See also in sourсe #XX -- [ Pg.331 ]

See also in sourсe #XX -- [ Pg.75 ]

See also in sourсe #XX -- [ Pg.748 ]




SEARCH



2,3-Oxidosqualene cyclase, lanosterol synthase

2,3-Oxidosqualene lanosterol cyclase

2.3- Oxidosqualene cycloartenol cyclase

A-cyclase

ACTH adenylate cyclase in action

ADP ribosyl cyclase

ADP-ribose cyclase

ADP-ribosyl cyclases

Abietadiene cyclase

Acetylcholine adenylyl cyclase inhibition

Activation of adenylate cyclase

Activation of adenylate cyclase activity

Activators of Soluble Guanylyl Cyclase

Adenosine receptor ligands Adenylyl cyclase

Adenyl cyclase

Adenyl cyclase activity

Adenyl cyclase glucagon

Adenyl cyclase hormonal activation

Adenyl cyclase hormone receptor model

Adenyl cyclase protein inhibitor

Adenyl cyclase system

Adenyl cyclase system subunits

Adenyl cyclase, stimulation

Adenyl cyclase/phosphokinase

Adenylate Cyclase-Dependent Signaling

Adenylate cyclase

Adenylate cyclase activation

Adenylate cyclase activator

Adenylate cyclase activity

Adenylate cyclase activity stimulation

Adenylate cyclase activity stimulatory effects

Adenylate cyclase activity, inhibition

Adenylate cyclase adrenergic receptors

Adenylate cyclase assay

Adenylate cyclase blood levels

Adenylate cyclase catalytic subunit

Adenylate cyclase cell culture

Adenylate cyclase characterization

Adenylate cyclase coupling

Adenylate cyclase coupling with dopamine receptors

Adenylate cyclase dopamine receptor

Adenylate cyclase dopaminergic receptors

Adenylate cyclase enzyme, effect

Adenylate cyclase factor

Adenylate cyclase hormones affecting

Adenylate cyclase inhibition

Adenylate cyclase lead inhibition

Adenylate cyclase magnesium ions

Adenylate cyclase mechanism

Adenylate cyclase mechanism transfer

Adenylate cyclase metabolism

Adenylate cyclase negative coupling

Adenylate cyclase opioid receptors

Adenylate cyclase pathway, triggering

Adenylate cyclase platelets

Adenylate cyclase postsynaptic

Adenylate cyclase postsynaptic nerve

Adenylate cyclase reaction catalyzed

Adenylate cyclase receptor linked

Adenylate cyclase receptor system

Adenylate cyclase signal transduction

Adenylate cyclase stimulants

Adenylate cyclase stimulation

Adenylate cyclase substituted-phenyl

Adenylate cyclase system

Adenylate cyclase toxic

Adenylate cyclase vanadium

Adenylate cyclase vasopressin-stimulated

Adenylate cyclase, G-proteins

Adenylate cyclase, adenylyl

Adenylate cyclase, in brain

Adenylate cyclase, stereochemical

Adenylate cyclase, thyroid hormones

Adenylate cyclase-cyclic adenosine

Adenylate cyclase-cyclic adenosine monophosphate system

Adenylate cyclases

Adenylyl Cyclase and cAMP as Second Messenger

Adenylyl Cyclases

Adenylyl cyclase

Adenylyl cyclase Regulation

Adenylyl cyclase Structure

Adenylyl cyclase adenosine binding

Adenylyl cyclase cAMP derived from

Adenylyl cyclase cascade, involvement

Adenylyl cyclase catalytic activity

Adenylyl cyclase signaling inhibition

Adenylyl cyclase signaling, disruption

Adenylyl cyclase, role

Adenylyl cyclase, role signal transduction

Adenylyl cyclase/cAMP system

Allene oxide cyclase

Aminotransferases cyclases

Atrial natriuretic peptide guanylyl cyclase binding

Blood vessels, adenylyl cyclases

Bordetella Adenylate cyclase

Calcium adenylyl cyclase regulation

Carbon monoxide guanylate cyclase activation

Cell signaling, adenylyl cyclase

Cell signaling, adenylyl cyclase inhibition

Chanoclavine cyclase

Chanoclavine-I cyclase

Classification adenylate cyclase

Coupling with adenylate cyclase

Cyclase Aromatic polyketide

Cyclase activity

Cyclase activity of Maytenus aquifolium

Cyclase inhibitor

Cyclase synthesis

Cyclase, artificial

Cyclase-associated protein

Cyclases

Cyclases, description

Cyclic AMP and adenyl cyclase

Cyclic Adenyl cyclase

Cyclic Guanylate cyclase

Cyclic nucleotides adenylyl cyclases

Cyclic nucleotides guanylyl cyclase

Cyclizations artificial cyclases

Cycloartenol cyclase

Cytoplasmic guanylate cyclase

Delta receptors adenylate cyclase

Dictyostelium discoideum cyclase

Dictyostelium discoideum cyclase activation

Dopamine-sensitive adenylate cyclase

Effects on adenylyl cyclase

Enzymes Adenylate cyclase

Enzymes oxidosqualene cyclase

Flupenthixol effects, adenylate cyclase

Formamidines cyclase

Forskolin, adenylyl cyclase

Forskolin, adenylyl cyclase activation

Forskolin, which is isolated from Coleus forskohlii, stimulates adenylate cyclase

G-protein-coupled adenylate cyclase-cAMP system

G-proteins adenylyl cyclase

Glucagon adenylate cyclase in action

Glutaminyl cyclase

Guanilate cyclase magnesium ions

Guanyl cyclase

Guanyl cyclases, transmembrane

Guanylate cyclase

Guanylate cyclase activation

Guanylate cyclase assay

Guanylate cyclase by nitric oxide

Guanylate cyclase cerebellum

Guanylate cyclase effects

Guanylate cyclase heme oxygenase

Guanylate cyclase moieties

Guanylate cyclase nitric oxide-mediated activation

Guanylate cyclase pathway

Guanylate cyclase radicals

Guanylate cyclase receptor system

Guanylate cyclase recombinant

Guanylate cyclase subunits

Guanylate cyclase-activating proteins

Guanylyl cyclase

Guanylyl cyclase cell-surface receptors

Guanylyl cyclase domain

Guanylyl cyclase, nitric oxide-dependent

Guanylyl cyclases

Guanylyl-cyclase activity

Heme cyclase

Hormone-activated guanylate cyclase

Humulene cyclase

Hydroperoxide cyclase

Inhibition adenylyl cyclase

Inhibition of adenylate cyclase

Inhibition of adenylyl cyclase

Inhibition of adenylyl cyclase activity

Insulin Adenylate cyclase

Insulin Guanylate cyclase

Intermediate lobe adenylate cyclase

Limonene cyclase

Lycopene -cyclase

Lycopene cyclases

Lycopene epsilon cyclase

Lycopene epsilon cyclase genes

Lycopene-beta-cyclase

Maytenus aquifolium cyclase activity

Membrane-bound and soluble guanylyl cyclases

Membrane-bound enzymes adenylate cyclase

Modulation of Insulin Secretion via Adenylate Cyclase and Phospholipase C (PLC)

Monoterpene cyclases

Neuroleptics, adenylate cyclase inhibition

Nitric oxide guanyl cyclase activated

Nitric oxide guanylyl cyclase activation

Nitric oxide sensitive guanylyl cyclase

Nucleotide cyclases

Nucleotide cyclases activation

Nucleotidyl cyclases

Oxidative cyclase

Oxidosqualene cyclase

Oxidosqualene cyclases

Oxidosqualenedanosterol cyclase

P-cyclase

Phosphorylation adenyl cyclase regulation

Pinene cyclase

Pituitary Adenylyl Cyclase-Activating Polypeptide

Pituitary adenylate cyclase

Pituitary adenylate cyclase-activating

Pituitary adenylate cyclase-activating peptide

Pituitary adenylate cyclase-activating peptide PACAP)

Pituitary adenylate cyclase-activating polypeptide

Pituitary adenylate cyclase-activating polypeptide-38 (PACAP

Platelet activation adenyl cyclase

Platelet activation guanyl cyclase

Platelet adenylate cyclase activation

Polyketide cyclase

Prostacyclin adenylate cyclase

Prostaglandin adenylate cyclase activation

Protein adenylate cyclase

Purines adenylate cyclase

Receptors guanylyl cyclase

Receptors with guanylate cyclase activity

Retinal guanylate cyclase gene

Salacia campestris cyclase activity

Second messengers adenylate cyclase control

Sesquiterpene cyclase

Sesquiterpene cyclases

Signal transduction adenylyl cyclase

Signaling adenylyl cyclase

Soluble guanylate cyclase

Soluble guanylate cyclase activation

Soluble guanylate cyclase activation mechanism

Soluble guanylate cyclase activation production

Soluble guanylate cyclase activation synthesis

Soluble guanylyl cyclase

Soluble guanylyl cyclases

Squalene 2,3-oxide.cycloartenol cyclase

Squalene cyclase

Squalene cyclases

Squalene epoxide cyclases

Squalene oxide cyclase

Squalene-hopene cyclase

Sterol and triterpene cyclases

Sterol cyclase

Sterol cyclases, evolution

Striatal adenylate cyclase activity

Striatal adenylate cyclase activity stimulation

Striatal adenylate cyclase, agonists

Terpene cyclase, function

Terpene cyclases

Terpene synthases (including cyclases)

The Membrane Receptor-Non-Adenylate-Cyclase System

The adenylate cyclase-cAMP system

Thyroid adenylyl cyclase

Tocopherol cyclase

Triterpene cyclase

Triterpene cyclases

Triterpenoids triterpene cyclase

© 2024 chempedia.info